The analyst price target for Qualys has been revised from $117 to $113, as analysts factor in updated assumptions around revenue growth, profit margins, and future P/E multiples following a series of recent price target reductions across the Street.
Analyst Commentary
Bearish analysts have been trimming their price targets on Qualys in a series of moves that collectively point to more cautious expectations around the stock. Recent cuts of US$4 to US$10 from multiple firms, including JPMorgan, highlight a reset in how near term risk and reward is being viewed.
While each report has its own angle, the common thread is a more guarded stance on how much investors should be willing to pay for Qualys under current assumptions on growth, margins, and future P/E multiples.
Bearish Takeaways
- Repeated target cuts clustered over a short period suggest bearish analysts are reassessing what they see as a rich valuation relative to their updated revenue and earnings assumptions.
- The reductions in price targets of US$4 to US$10 indicate concerns that execution risks or slower than previously assumed growth could limit upside from current levels.
- Some bearish analysts are tying lower targets to more conservative P/E multiples, reflecting a view that the stock may need a wider margin of safety if near term performance does not fully match prior expectations.
- The breadth of cuts, including from large firms such as JPMorgan, signals that caution is not isolated to a single view and that a portion of the Street is more focused on downside and volatility risk.
What's in the News
- The Trump administration is reported to be weighing whether to enlist private companies in cyberwarfare efforts, which could influence how investors think about cybersecurity vendors such as Qualys, although the article does not name specific beneficiaries (New York Times, periodical).
- Qualys issued earnings guidance for the first quarter of 2026, with expected revenues between US$172.5 million and US$174.5 million and GAAP net income per diluted share in a range of US$1.29 to US$1.36, based on an assumed 21% effective tax rate and approximately 36.0 million diluted shares (company guidance).
- For full year 2026, Qualys projected revenues between US$717.0 million and US$725.0 million and GAAP net income per diluted share between US$5.20 and US$5.48, based on approximately 35.4 million diluted shares (company guidance).
- On February 5, 2026, Qualys increased its equity buyback authorization by US$200 million, bringing the total plan authorization to US$1.6 billion (company announcement).
Valuation Changes
- Fair Value Estimate reduced from US$117 to US$113, reflecting a slightly lower central value for the shares in the updated model.
- Discount Rate adjusted marginally from 8.44% to 8.42%, indicating only a very small change in the assumed risk profile.
- Revenue Growth moved from 7.80% to 6.54%, pointing to more conservative expectations for how quickly sales may expand over time.
- Net Profit Margin refined from 25.21% to 24.97%, a modest pullback in assumed profitability on each dollar of revenue.
- Future P/E lowered from 24.59x to 23.52x, implying a slightly lower multiple applied to expected earnings in the updated valuation work.
Have other thoughts on Qualys?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystLowTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystLowTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystLowTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.